Watch leading CDMOs share their current capabilities, facility locations, and timelines—helping you identify the right partners for your cell and gene development and manufacturing needs. Explore the fast-growing field of cell and gene therapy, including: - Cell sourcing and expansion - Vector design and gene therapy delivery mechanisms - Formulation development and GMP-compliant processes ensuring...
Join us at the Houston Life Sciences Commercial Real Estate Conference, where researchers, developers, investors, and real estate professionals converge to examine the forces shaping one of the fastest-growing innovation hubs in the country. Houston’s world-class medical institutions, biotech startups, and research facilities are driving breakthroughs in healthcare, pharmaceuticals, and medical technology. This event will highlight...
In this Capabilities Update, industry leaders will share where AI is delivering value today—from hit-to-lead optimization and analytical method development to model-informed process development and digital CPV/QMS—and how CDMOs and sponsors can collaborate to reduce cycle times, improve quality, and de-risk scale-up. Attendees will gain a practical CDMO readiness checklist and insights into sponsor expectations...
2026 marks a turning point in life sciences — the year AI moves from concept to core capability. With ELaiN, the world’s first AI-native ELN, Sapio is leading this transformation, making software simple to use and empowering labs to think faster and innovate smarter. This is your chance to connect with industry leaders, network with peers, and...
As life sciences manufacturers progress along their digital maturity journey, validation data is increasingly recognized as a strategic asset rather than a compliance artifact. In this session, experts will illustrate how digitally mature organizations leverage Digital Validation Technologies (DVTs) as a core component of their broader digital ecosystem. Attendees will gain a clear understanding of...
Ultrafiltration/Diafiltration (UF/DF) processes that look robust at the development scale often expose critical weaknesses during scale-up or tech transfer—resulting in capacity constraints, excessive manual intervention, delayed timelines, or manufacturing risk. In many cases, these issues trace back to early UF/DF decisions that seemed reasonable at the time but didn’t fully account for scalability, system design,...
Back By Popular Demand! Our third Clinical Leader Live on AI will go beyond the buzzwords to focus on what’s actually working in clinical operations. You will hear about some of the newest real-world applications, lessons learned from early adopters, and how to spot hype before it costs you time or money. Registration is free...
Join Us for the BVS and BioMed Realty Biotech Community Event! Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. The vendor fair is held at The Forum, in the same building as Amgen and next to Genentech, right in...
Cell therapy development is entering a phase where complexity can no longer be managed by intuition alone. In this Cell & Gene Live, Cell & Gene’s Chief Editor, Erin Harris, is joined by Timothy Lu, M.D., Ph.D, Co-Founder and CEO of Senti Biosciences and Claire Aldridge, Ph.D., Board of Directors/Scientific Advisor, to explore how AI...
Bringing a semi-solid topical drug from the lab to commercial manufacturing is anything but straightforward. Join this expert-led webinar to explore the critical formulation, processing, and scale-up considerations that influence product quality, stability, and patient experience, while learning how Quality by Design (QbD) principles help de-risk development at every stage. Gain practical insights into topical...
